Friday, July 17, 2026

11:15 AM - 1:15 PM

---

Details

The proposed WCP2026 Symposia, “Emerging Strategies Aiming Myeloid Cell Biology in the era of cancer immunotherapy” will focus on introducing the current state-of-the-art in the field of discovery of myeloid immune checkpoints, which has driven novel therapeutic options for cancer patients. The symposia will provide an overview of the path from a deeper understanding of myeloid cell biology to discovery of promising novel targeting strategies. This session will advance the science and application of myeloid checkpoints-targeted immunotherapy by bringing together scientists and clinicians in academia to provide high-level perspectives. This session will also touch on preclinical and translational studies of future applications of myeloid cell-based immunotherapy.

---

Session chair